Determination of intracellular organelles implicated in daunorubicin cytoplasmic sequestration in multidrug-resistant MCF-7 cells using fluorescence microscopy image analysis
C. Bour-dill et al., Determination of intracellular organelles implicated in daunorubicin cytoplasmic sequestration in multidrug-resistant MCF-7 cells using fluorescence microscopy image analysis, CYTOMETRY, 39(1), 2000, pp. 16-25
Background: Anthracycline resistance is known to be mediated by P-glycoprot
ein (P-gp) or multidrug-resistance related protein (MRP) as well as intrace
llular sequestration of drugs.
Methods: The resistance phenotype of doxorubicin-selected MCF-7(DXR) human
breast adenocarcinoma cell line was characterized by cellular and nuclear d
aunorubicin efflux, P-ey and MRP expression and apoptosis induction. Daunor
ubicin sequestration was investigated through organelle markers (lysosomes,
endoplasmic reticulum and Golgi apparatus) and daunorubicin co-localizatio
n by dual-color image analysis fluorescence microscopy using high numerical
aperture objective lenses to achieve the smallest field depth and the best
lateral resolution. Signal to noise and specificity ratios were optimized
for daunorubicin and organelle fluorescent probes labeling.
Results: tin original image analysis procedure was developed to investigate
daunorubicin and organelles co-localization. The reliability of the image
analysis was controlled through chromatic shift and intensity linearity mea
surement using calibrated microbeads. The main contribution (65%) of Golgi
vesicles in daunorubicin sequestration was demonstrated Although no rationa
l relationship could be established between daunorubicin sequestration and
apoptosis induction, no apoptosis was observed in MCF-7(DXR) cells.
Conclusions: In addition to P-glycoprotein mediated drug efflux and without
MRP overexpression, MCF-7(DXR) daunorubicin resistance phenotype involves
drug sequestration within intracellular resides identified as Golgi vesicle
s and resistance to apoptosis induction. (C) 2000 Wiley-Liss, Inc.